| Literature DB >> 28672787 |
Laura Contalbrigo1, Marta De Santis2, Marica Toson3, Maria Montanaro4, Luca Farina5, Aldo Costa6, Felice Alfonso Nava7.
Abstract
Drug addiction is a major care and safety challenge in prison context. Nowadays, rehabilitation and specific therapeutic programs are suggested to improve health and well-being of inmates during their detention time and to reduce substance abuse relapse after release from prison. Among these programs, several studies reported the benefits for inmates coming from animal assisted interventions. In this pilot controlled study, we investigated the efficacy of a dog assisted therapy program addressed to 22 drug addicted male inmates housed in an attenuated custody institute in Italy. The study lasted six months, the treated group (12 inmates) was involved once a week for one hour in 20 dog assisted therapy sessions, whereas the control group (10 inmates) followed the standard rehabilitation program. One week before the beginning and one week after the end of the sessions, all inmates involved were submitted to symptom checklist-90-revised and Kennedy axis V. Inmates involved in the dog assisted therapy sessions significantly improved their social skills, reducing craving, anxiety and depression symptoms compared to the control group. Despite the limitation due to the small number of inmates enrolled and to the absence of follow up, we found these results encouraging to the use of dog assisted therapy as co-therapy in drug addicted inmates rehabilitation programs, and we claim the need of more extensive study on this subject.Entities:
Keywords: animal assisted interventions; dog assisted therapy; drug addiction; inmates
Mesh:
Year: 2017 PMID: 28672787 PMCID: PMC5551121 DOI: 10.3390/ijerph14070683
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Activities performed during dog assisted therapy (D.A.T.) sessions.
Figure 2Participant flow diagram for the case-control study.
Sociodemographic characteristics and drug use of participants to the study.
| Demographic Characteristics | Dog Assisted Therapy (D.A.T.) Program ( | Standard Program ( |
|---|---|---|
| Age (mean ± SD in years) | 35.5 ± 13.83 | 42.9 ± 9.1 |
| Primary School Education (%) | 22.2 | 0 |
| Secondary School Education (%) | 77.8 | 88.9 |
| High School Education (%) | 0 | 11.1 |
| Degree or PhD (%) | 0 | 0 |
| Prison Stay (median in months) | 12 | 12 |
| Pharmacological treatment (%) | 77.7 | 55.5 |
D.A.T. group. SCL-90-R results.
| Variable | Mean ± SD | ||
|---|---|---|---|
|
|
| ||
| Somatization | 0.98 ± 0.89 | 0.21 ± 0.24 | 0.0227 |
| Obsessive-compulsive symptoms | 1.07 ± 0.61 | 0.46 ± 0.29 | 0.0102 |
| Interpersonal sensitivity | 0.60 ± 0.59 | 0.23 ± 0.24 | 0.1754 * |
| Depression | 1.34 ± 0.84 | 0.45 ± 0.32 | 0.0139 |
| Anxiety | 1.39 ± 0.95 | 0.44 ± 0.35 | 0.0130 |
| Hostility | 0.57 ± 0.58 | 0.43 ± 0.36 | 0.4153 * |
| Phobic anxiety | 0.46 ± 0.55 | 0.06 ± 0.07 | 0.0703 * |
| Paranoid ideation | 1.17 ± 0.72 | 0.54 ± 0.49 | 0.0175 |
| Psychoticism | 0.73 ± 0.62 | 0.19 ± 0.16 | 0.0173 |
| Sleep disorders | 1.78 ± 0.53 | 0.63 ± 0.59 | 0.0002 |
| Global severity index | 1.01 ± 0.54 | 0.35 ± 0.19 | 0.0056 |
* p-value > 0.05.
Control group. SCL-90-R results.
| Variable | Mean ± SD | Wilcoxon Signed-Rank Test | |
|---|---|---|---|
|
|
| ||
| Somatization | 1.17 ± 1.30 | 0.65 ± 0.74 | 0.2207 |
| Obsessive-compulsive symptoms | 1.37 ± 1.05 | 0.83 ± 0.53 | 0.2026 |
| Interpersonal sensitivity | 0.70 ± 0.51 | 0.52 ± 0.55 | 0.5403 |
| Depression | 1.10 ± 0.77 | 0.83 ± 0.48 | 0.6101 |
| Anxiety | 1.07 ± 0.83 | 0.73 ± 0.41 | 0.3580 |
| Hostility | 0.67 ± 0.75 | 0.53 ± 0.54 | 0.7208 |
| Phobic anxiety | 0.82 ± 1.40 | 0.35 ± 0.51 | 0.2578 |
| Paranoid ideation | 0.86 ± 0.74 | 0.83 ± 0.59 | 0.9188 |
| Psychoticism | 0.84 ± 0.77 | 0.66 ± 0.41 | 0.6831 |
| Sleep disorders | 1.89 ± 1.47 | 1.00 ± 1.02 | 0.0411 * |
| Global severity index | 1.00 ± 0.82 | 0.67 ± 0.43 | 0.5400 |
* p-value < 0.05.
Figure 3(a) SCL-90-R. Significant reduction of depression symptoms comparing inmates involved in the D.A.T. program and the control group (p-value < 0.05); • = outlier values; (b) SCL-90R. Significant reduction of paranoid ideation symptoms comparing inmates involved in the D.A.T. program and the control group (p-value < 0.05); (c) SCL-90R. Significant reduction of sleep disorders comparing inmates involved in the D.A.T. program and the control group (p-value < 0.05); • = outlier value.
Figure 4(a) SCL-90-R. Significant reduction of anxiety symptoms comparing inmates involved in the D.A.T. program and the control group (p-value < 0.1); (b) SCL-90R. Significant reduction of psychotic symptoms comparing inmates involved in the D.A.T. program and the control group (p-value < 0.1).
Comparison between D.A.T. and Control group (ΔT-T). SCL-90-R results.
| Variable | Mean ± SD | Wilcoxon Signed-Rank Test | |
|---|---|---|---|
| D.A.T. Group | Control Group | ||
| Somatization | 0.78 ± 0.78 | 0.29 ± 0.92 | 0.2152 |
| Obsessive-compulsive symptoms | 0.61 ± 0.55 | 0.26 ± 0.77 | 0.2881 |
| Interpersonal sensitivity | 0.36 ± 0.71 | 0.07 ± 0.75 | 0.5346 |
| Depression | 0.89 ± 0.84 | 0.02 ± 0.65 | 0.0468 * |
| Anxiety | 0.94 ± 0.89 | 0.16 ± 0.73 | 0.0562 ** |
| Hostility | 0.17 ± 0.50 | −0.04 ± 0.66 | 0.4772 |
| Phobic anxiety | 0.37 ± 0.56 | 0.32 ± 1.31 | 0.1133 |
| Paranoid ideation | 0.64 ± 0.62 | −0.13 ± 0.76 | 0.0272 * |
| Psychoticism | 0.54 ± 0.55 | 0.02 ± 0.78 | 0.0926 ** |
| Sleep disorders | 1.13 ± 0.51 | 0.62 ± 1.22 | 0.0201 * |
| Global severity index | 0.76 ± 0.45 | 0.12 ± 0.67 | 0.0627 ** |
* p-value < 0.05; ** p-value < 0.1.
D.A.T. group. Kennedy Axis V results.
| Variable | Mean ± SD | Wilcoxon Signed-Rank Test | |
|---|---|---|---|
|
|
| ||
| Psychological impairment | 60.42 ± 7.22 | 69.17 ± 8.48 | 0.0017 |
| Social skills | 58.75 ± 10.25 | 68.33 ± 12.85 | 0.0018 |
| Violence | 62.92 ± 10.10 | 70.42 ± 10.97 | 0.0021 |
| Occupational skills | 64.17 ± 9.96 | 70.83 ± 12.94 | 0.0027 |
| Substance craving | 59.17 ± 13.29 | 67.50 ± 13.57 | 0.0042 |
| Medical impairment | 83.33 ± 10.73 | 82.92 ± 9.16 | 0.6376 * |
| Ancillary impairment | 60.00 ± 8.53 | 65.83 ± 8.75 | 0.0026 |
* p-value > 0.05.
Control group. Kennedy Axis V results.
| Variable | Mean ± SD | Wilcoxon Signed-Rank Test | |
|---|---|---|---|
|
|
| ||
| Psychological impairment | 63.75 ± 8.82 | 69.17 ± 10.62 | 0.0058 |
| Social skills | 64.17 ± 9.00 | 68.33 ± 11.15 | 0.0115 |
| Violence | 72.50 ± 14.22 | 76.25 ± 12.64 | 0.0261 |
| Occupational skills | 65.83 ± 13.11 | 69.58 ± 14.37 | 0.0052 |
| Substance craving | 62.50 ± 9.65 | 66.67 ± 10.08 | 0.0056 |
| Medical impairment | 72.08 ± 11.57 | 77.08 ± 12.69 | 0.0092 |
| Ancillary impairment | 62.08 ± 8.65 | 66.67 ± 10.73 | 0.0111 |
Comparison between D.A.T. and Control group (ΔT1-T0). Kennedy Axis V results.
| Variable | Mean ± SD | ||
|---|---|---|---|
| D.A.T. Group | Control Group | ||
| Psychological impairment | 8.75 ± 3.11 | 5.42 ± 4.50 | 0.0464 * |
| Social skills | 9.58 ± 4.50 | 4.17 ± 4.17 | 0.0058 * |
| Violence | 7.50 ± 5.00 | 3.75 ± 4.83 | 0.0750 |
| Occupational skills | 6.67 ± 5.36 | 3.75 ± 3.11 | 0.1174 |
| Substance craving | 2.08 ± 5.82 | 4.17 ± 3.59 | 0.3028 |
| Medical impairment | −0.42 ± 6.89 | 5.00 ± 4.77 | 0.0356 |
| Ancillary impairment | 5.83 ± 3.59 | 4.58 ± 4.50 | 0.4599 |
* p-value < 0.05.